Drugs / Simmiparib
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02993913 | Dec 2016 → Dec 2018 | cancer | Shanghai Acebright Pharmaceuticals Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Simmiparib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02993913 ↗ |
| Route | Oral | “Simmiparib Tablets, oral administration” NCT02993913 ↗ |